0001753926-24-000518.txt : 20240312
0001753926-24-000518.hdr.sgml : 20240312
20240312160551
ACCESSION NUMBER: 0001753926-24-000518
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Friedberg Ezra M
CENTRAL INDEX KEY: 0001679440
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41964
FILM NUMBER: 24742084
MAIL ADDRESS:
STREET 1: 1000 MARINA BOULEVARD
STREET 2: SUITE 250
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chromocell Therapeutics Corp
CENTRAL INDEX KEY: 0001919246
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863335449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 685 US HIGHWAY ONE
CITY: NORTH BRUNSWICK
STATE: NJ
ZIP: 08902
BUSINESS PHONE: 9176446313
MAIL ADDRESS:
STREET 1: 685 US HIGHWAY ONE
CITY: NORTH BRUNSWICK
STATE: NJ
ZIP: 08902
4/A
1
ownership.xml
X0508
4/A
2024-02-21
2024-02-21
0
0001919246
Chromocell Therapeutics Corp
CHRO
0001679440
Friedberg Ezra M
C/O CHROMOCELL THERAPEUTICS CORPORATION
4400 ROUTE 9 SOUTH, SUITE 1000
FREEHOLD
NJ
07728
1
0
0
0
0
Common Stock
2024-02-21
4
P
0
16667
6.00
A
545721
D
This Form 4/A is being filed to include the purchase of 16,667 shares of the Issuer's common stock (the "Common Stock") in the Issuer's initial public offering, in addition to the securities originally reported on the Form 4 filed by the reporting person on February 21, 2024.
/s/ Ezra Friedberg
2024-03-12